Metformin’s Multifaceted Benefits in Pregnancy and Longevity – Fertility Plus
Fertility Plus shared a post on LinkedIn:
“Metformin is emerging as a true ‘aspirin of the 21st century’. Originally a type 2 diabetes drug, it now sits at the crossroads of gestational diabetes care, preeclampsia prevention, oncology, and healthy ageing.
Mechanistically, metformin inhibits mitochondrial complex I, activates AMPK, and suppresses mTOR, leading to reduced insulin resistance, lower glucose output, dampened inflammation, and decreased angiogenesis (e.g., VEGF signalling). These pathways are central not only to metabolic disease but also to placental dysfunction and tumor biology.
Clinically, meta-analyses indicate that in gestational diabetes, metformin provides glycemic control comparable to insulin, often with less gestational weight gain and fewer neonatal hypoglycemia or macrosomia events. A key RCT in obese pregnancy did not reduce large-for-gestational-age infants (primary outcome) but did reduce preeclampsia rates, suggesting vascular benefits beyond glucose control.
Observational cohorts link metformin use to lower cancer incidence and improved survival, and ageing studies connect it to improved longevity markers, though definitive randomized evidence is still in progress.
For clinicians, researchers, and policymakers, the question is shifting from ‘Does metformin only treat diabetes?; to ‘Where else should we be using it—cautiously and strategically?’
How are you currently integrating metformin into pregnancy, oncology, or cardiometabolic pathways in your practice or research? Let’s discuss!
Metformin, Diabetes Care, Oncology, Healthy Aging, Gestational Diabetes, Preeclampsia, Research Discussion
Romero R. Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity. American Journal of Obstetrics and Gynecology. 2017;217(3):282–302
Fertility Plus
92 Harley Street, London
Tel: 0800 022 6038
Email: [email protected]
Website: www.fertilityplus.org.uk”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Mar 16, 2026, 13:30Simon Meagher and Rabih Chaoui Discuss Fetal Heart Scanning in the Latest ISUOG Podcast – ISUOG
-
Mar 16, 2026, 12:58Exploring the Link Between Adenomyosis and Proliferative Endometrial Disorders – Fertility and Sterility
-
Mar 16, 2026, 12:55Nicola Pozzi: A New Mechanism to Reduce Thrombus Formation Without Increasing Bleeding Risk
-
Mar 16, 2026, 12:44Endometriosis Awareness Month Virtual Issue! – ISUOG
-
Mar 16, 2026, 12:30Jeanne Conry: When the Government Intervenes, Women Die
-
Mar 16, 2026, 12:23Magdalena Simonis Highlights the Need to Change the Rhetoric on Endometriosis
-
Mar 16, 2026, 12:00Julia Chain Highlights Fertility Preservation as Part of Women’s Health Campaign – HFEA
-
Mar 15, 2026, 15:26Watching Life Begin: Scientists Track Embryo Implantation in Real Time! – Science Magazine
-
Mar 15, 2026, 15:03Reem Abu-Rustum Spotlights Fetal Situs in New ISUOG Quiz – ISUOG